A network of experts in reproductive and children’s environmental health

PEHSU Annual Meeting Scientific Sessions

Monday, June 3, 2019 - Washington, DC


These webinars are part of an ongoing series of educational presentations by experts on issues that focus on current and emerging aspects of pediatric and reproductive environmental health.

These presentations focus on the impact of environmental exposures to chemicals on human health at the vulnerable stages of in utero and pediatric development. A number of topics will be included – all of them relevant to questions of exposure and health effects, with consideration of risk reduction. Speakers will include physicians and PhD subject matter experts, as well as individuals with expertise in areas such as home assessment, laboratory analysis, and risk communication.
 
*ALL SESSIONS LISTED ARE AVAILABLE IN THE PEHSU NATIONAL CLASSROOM*
 
 
Air Quality, TENDR, and PEHSUs

Presenters & Topics Covered

Moderator - Mark Miller, MD, MPH, Region 9 PEHSU
  • Overview of TENDR - Project TENDR: Targeting Environmental Neuro-Developmental Risks
    • Presenter: Laura Anderko, PhD, RN, Region 3 PEHSU
  • Healthy Air, Health Brain: Advancing Air Pollution Policy to Protect Children’s Health
    • Presenter: Devon Corcia Payne-Sturgis, DrPH, Assistant Professor, Maryland Institute for Applied Environmental Health

Learning Objectives

By the end of this module, participants should be able to:
  • Describe the focus of the consensus statement developed and published by Project TENDR
  • Describe two key mechanisms of neurological effects of air pollution
  • Identify air pollutants that have been associated with neurodevelopmental effects
  • Describe policy options to reduce air pollution exposures
 Preview.png Take_Course_Button.png
Reproductive Environmental Health

Presenters & Topics Covered

Moderator - Blair Wylie, MD, MPH, FACOG, Region 1 PEHSU
  • Marijuana and Pregnancy
    • Presenter: Torri Metz, MD, MS, FACOG, Associate Professor, Obstetrics and Gynecology, Director of Perinatal Research, University of Utah Health
  • Message Mapping Activity
    • Led by: Susan Buchanan, MD, MPH, FAAFP, Region 5 PEHSU

Learning Objectives

By the end of this module, participants should be able to:
  • Define prevalence of marijuana use in pregnancy and reported reasons for use.
  • Counsel women regarding the risks of marijuana use during pregnancy and lactation based on the current evidence.
  • Create health messaging for patients around marijuana use in pregnancy
Preview.png Take_Course_Button.png
Public Health Messaging: Science of Communicating

Presenters & Topics Covered

Moderator - Jerome Paulson, MD, FAAP, PEHSU National Program Office
  • Presenter: Edward (Ed) Maibach, PhD, MPH, Professor, George Mason University, Director of Center for Climate Change Communication

Learning Objectives

By the end of this module, participants should be able to:
  • Describe two evidence-based guiding heuristics for public health communication and behavior change programs
 Preview.png Take_Course_Button.png

Continuing Education 
To receive continuing education (CE) for the Scientific Sessions:
  • View the recorded webinar on the PEHSU National Classroom
  • Please visit TCEO and follow these 9 Simple Steps before July 9, 2021.
  • You need your own TCEO account
  • Search for the activity with this keyword: 
    • Air Quality, TENDR, and PEHSUs OR WD2588-060319A OR click here
    • Reproductive Environmental Health: Marijuana Use in Pregnancy and While Breastfeeding  OR WD2588-060319B OR click here
    • The Science of Public Health Messaging: Two Guiding Heuristics OR WD2588-060319C OR click here
  • Complete the Evaluation at www.cdc.gov/TCEOnline
  • Pass the posttest at 80% (Posttest consists of a mix of five multiple choice and true/false questions.)
FEES: No fees are charged for CDC’s CE activities.

 

Grand Rounds Accreditation Statements


Disclaimers

This material was supported by the American Academy of Pediatrics (AAP) and funded (in part) by the cooperative agreement FAIN: 5 NU61TS000237-05 along with the American College of Medical Toxicology and funded (in part) by the cooperative agreement FAIN: 5U61TS000238-05 from the Agency for Toxic Substances and Disease Registry (ATSDR).
 
Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-95877701. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications.